EXPOSE YOUR PATIENTS TO THE BENEFITS OF TOBI®1,2

In pivotal clinical studies, TOBI has been proven to:

lady
 
 
 
Important Safety Information full Prescribing Information www.fda.gov/medwatch

References:

  • TOBI [package insert]. East Hanover, NJ: Novartis Pharmaceuticals Corporation; 2009.
  • Ramsey BW, Pepe MS, Quan JM, et al. Intermittent administration of inhaled tobramycin in patients with cystic fibrosis. N Engl J Med. 1999;340:23-30.